Researching Economical Adjuvants to Cancer Therapy
Eligible age
18–45 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to learn if beta-glucan (a dietary fiber) improves the function of the immune system in adults. It will also tell the investigators if combining beta-glucan with single bouts of exercise provides additional benefit. The main questions it aims to answer are: 1. Does beta-glucan change the ability of immune cells to recognize cancer cells? 2. Does exercise change the type of immune cells in the blood? Researchers will compare beta-glucan to a placebo (a look-alike substance with no effect) to see if beta-glucan could improve immune function against cancer. Participants will: 1. Take beta-glucan or a placebo daily for 4 weeks. 2. Visit the laboratory for three exercise tests. 3. Provide blood samples so researchers can study immune system cells.
Sponsor: Florida State University
You may qualify if…
- ✓ Physically fit enough to engage in maximal exercise.
You may not qualify if…
- ✕ BMI \> 40 kg/m2
- ✕ Stage 2 hypertension (140/90 mmHg)
- ✕ Type I or II diabetes
- ✕ Autoimmune diseases
- ✕ Overt cardiovascular, respiratory, or neurological disease (e.g., previous heart attack, pacemaker, heart failure, asthma)
- ✕ Hormone replacement therapy (e.g., androgens, estrogens)
- ✕ Daily medication usage that may affect immune function (e.g., beta blockers, NSAIDs, corticosteroids, allergy medications)
- ✕ Current antibiotic use
Where it's recruiting
Tallahassee
Source: ClinicalTrials.gov · NCT07305259 · last updated 2025-12-26